[1]
Fathi, A., Vafaie, M., Amani, F. and Mohebbi, N. 2017. Evaluation of Osveral efficacy in reducing ferritin levels in patients with thalassemia major. International Journal of Basic & Clinical Pharmacology. 6, 11 (Oct. 2017), 2556–2560. DOI:https://doi.org/10.18203/2319-2003.ijbcp20174770.